Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of ELL as E3 ubiquitin ligase

A ligase, ubiquitin technology, applied in the application field of ELL as E3 ubiquitin ligase, can solve problems such as inactivation and non-expression

Active Publication Date: 2016-05-25
INST OF AQUATIC LIFE ACAD SINICA
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Of note, point mutations in FBW7 in human cancers can result in its inactivation and likely non-expression (Farrell and Ears 2014)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of ELL as E3 ubiquitin ligase
  • Application of ELL as E3 ubiquitin ligase
  • Application of ELL as E3 ubiquitin ligase

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0077] Example 1, ELL promotes c-Myc degradation

[0078] The amino acid sequence of protein c-Myc is sequence 2, and the nucleotide sequence of its coding gene is sequence 1;

[0079] The amino acid sequence of protein ELL is sequence 4, and the nucleotide sequence of its coding gene is sequence 3.

[0080] The above sequence was artificially synthesized.

[0081] 1. ELL reduces the expression of exogenous Myc

[0082] The plasmid HA-c-Myc (WT) expressing c-Myc is a plasmid obtained by inserting the c-Myc coding gene into the XbaI and BamHI sites of the pCMV-HA vector (Clontech);

[0083] The plasmid HA-ELL expressing ELL is a plasmid obtained by inserting the coding gene of ELL into the SalI and KpnI sites of the pCMV-HA vector;

[0084] Plasmid HA-empty is the pCMV-HA vector.

[0085] Plasmids HA-ELL and HA-empty were co-transfected with HA-c-Myc(WT) at a mass ratio of 1:1 to HEK293 cells. On the second day after transfection, the supernatant was collected for Western ...

Embodiment 2

[0102] Example 2, ELL acts as an E3 ubiquitin ligase to degrade c-Myc protein

[0103] 1. ELL can enhance the ubiquitination of c-Myc

[0104] In order to verify the type of protein degradation caused by ELL, inhibitors were used, including chloroquine (lysosomal proteolysis inhibitor, Chlq) (Sigma, 87111906), ammonium chloride (lysosomal proteolysis inhibitor, NH 4 CL) (Sinopharm, 12125-02-9), AICAR (autophagy inhibitor) (Cayman, 2627-69-2) and MG132 (proteasome inhibitor) (Sigma, M8699) to determine whether they can block ELL-mediated degradation of c-Myc.

[0105] Plasmid HA-ELL, plasmid HA-ELL and plasmid HA-c-Myc were transfected into HEK293 cells respectively. On the second day after transfection, Chlq and AICAR were added to the cell culture medium respectively, and the final concentrations of Chlq and AICAR reached 20mM, continue to culture for 6 hours, collect the supernatant for Western blot detection, the antibody used is shown in the figure. Take no inhibitor as...

Embodiment 3

[0175] Example 3, ELL inhibits the tumor growth of colon xenografts

[0176] The HT116 cells transfected with pHAGE-control, the HT116 cells transfected with pHAGE-ELL, and the HT116 cells transfected with pHAGE-ELL (C595A) in Example 2 were subjected to transplantation tumor growth experiments: 15 male nude mice were randomly divided into 3 groups , 5 in each group, three groups of nude mice were subcutaneously injected with the above three different cell lines, and the amount of cells injected into each nude mouse was 2×10 6 indivual. From the third week, the length, width, and height of the tumor were measured weekly and the tumor volume was calculated using V=π.abc / 6 (Flatz et al. 2010). After 6 weeks, the nude mice were sacrificed, the weight of the tumor was measured and the corresponding gene expression was analyzed. Lung tissues were analyzed histologically after HE staining.

[0177] Tumor volume results such as Figure 6 A and 6B, the tumor growth rate of HCT116 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of ELL as an E3 ubiquitin ligase. The application of ELL protein or truncated protein of the ELL protein to at least one of 1-6: 1, a protein product for degrading c-Myc is prepared; 2, the ELL protein or the truncated protein of the ELL protein is used as the E3 ubiquitin ligase; 3, a product for inhibiting tumor cell proliferation is prepared; 4, a product for inhibiting tumorigenesis is prepared; 5, a product for identifying or assisting in identifying whether tissue to be detected is tumor tissue or not is prepared; 6, a product for identifying or assisting in identifying whether a patient to be detected is a tumor patient or not is prepared. The experiment proves that ELL is combined with c-Myc and induces c-Myc to be degraded through proteasome, in-vivo and in-vitro studies both indicate that the ELL has the characteristic of the E3 ubiquitin ligase, can inhibit tumor cell proliferation and tumorigenesis, can be used as a molecular marker for tumor clinical diagnosis, and can be used for preparing the medicine or a kit for inhibiting tumors and a kit for diagnosing the tumors as the novel E3 ubiquitin ligase of c-Myc.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to an application of ELL as an E3 ubiquitin ligase. Background technique [0002] The gene product of ELL was first identified as a translocation fusion (MLL-ELL) with the MLL gene in acute myeloid leukemia (AML) (Thirman et al. 1994). Further biochemical studies found that ELL is a transcription elongation factor. In vitro (Invitro), it increases the transcription elongation activity of RNA polymerase II. Later in vivo studies (Invivo) revealed that it is associated with transcriptionally active sites of genes (Eissenberg et al. 2002, Shilatifard et al. 1996). ELL is part of two distinct elongation complexes, the super elongation complex (SEC) and the small elongation complex (LEC) (Hu et al. 2013, Luo et al. 2012, Smith and Shilatifard 2013). As one of the most active forms of the positive transcriptional elongation factor (P-TEFb), the super elongation complex (SEC) performs sever...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N9/00A61K38/43A61P35/00G01N33/574G01N33/573
CPCA61K38/00C12N9/93C12Y603/02019G01N33/573G01N33/57419G01N2333/90
Inventor 肖武汉陈瑜姬伟周迟
Owner INST OF AQUATIC LIFE ACAD SINICA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com